Anti-trust regulator Competition Commission of India (CCI) has approved speciality chemicals major PCBL’s proposed acquisition of a 100 per cent stake in Aquapharm Chemicals. The CCI has granted its approval to the deal under the green channel route. Under the green channel route, a transaction that does not raise any risk of an appreciable adverse effect on competition is deemed to be approved on being intimated to the fair-trade regulator.
The transaction relates to PCBL's proposal to acquire 100 per cent equity share capital of Aquapharm Chemicals from the existing shareholders of the company i.e., (members of Desai Group and Mangwani Group). After the completion of the transaction, Aquapharm Chemicals will be a wholly-owned subsidiary of PCBL.
PCBL is primarily engaged in the business of manufacturing & sale of carbon black and sale of power.